{"Background": [132, 394, 0], "Purpose": [395, 551, 0], "Methods": [552, 960, 0], "Results": [961, 1615, 0, 9339, 10845, 1], "Conclusion": [1616, 1822, 0], "Introduction": [1823, 3843, 0], "Study Design and Setting": [3867, 5087, 0], "Participants": [5088, 6283, 0, 9348, 9470, 0], "Variables and Data Collection": [6284, 7300, 0], "Data Sources/Measurements": [7301, 7772, 0], "Bias": [7773, 8159, 0], "Study Size": [8160, 8316, 0], "Statistical Analysis": [8317, 9338, 0], "Materials and Methods": [3844, 9338, 1], "Descriptive Data": [9471, 10167, 0], "Outcome Data": [10168, 10845, 0], "Outcomes Based on Anti-RBD Antibody Quantitation": [10860, 12350, 0], "Outcomes Based on Vaccination Status": [12351, 12891, 0], "Main Results": [10846, 12891, 1], "Discussion": [12892, 16845, 0], "Limitations": [16846, 17227, 0]}